Background Since the publication of the British Thoracic Society (BTS) Guideline on the
'Management of opportunistic mycobacterial infections' in 2000, our understanding of the …

Seemingly innocuous nontuberculous mycobacteria (NTM) species, classified by their slow
or rapid growth rates, can cause a wide range of illnesses, from skin ulceration to severe …

Two mycobacteriophages were administered intravenously to a male with treatment-
refractory Mycobacterium abscessus pulmonary infection and severe cystic fibrosis lung …

Mycobacterium abscessus, a multidrug-resistant nontuberculous mycobacterium, has
emerged as a major pathogen affecting people with cystic fibrosis (CF). Although originally …

The taxonomic position of members of the Mycobacterium abscessus complex has been the
subject of intensive investigation and, in some aspects confusion, in recent years as a result …

Mycobacterium abscessus is an opportunistic pathogen whose treatment is confounded by
widespread multidrug resistance. The therapeutic use of bacteriophages against …

Rationale: Mycobacterium abscessus is a significant threat to individuals with cystic fibrosis
(CF) because of innate drug resistance and potential transmission between patients. Recent …

Mycobacterium abscessus (MAB) is an emerging pathogen that leads to chronic lung
infections. To date, the global population structure of non-cystic fibrosis (CF) MAB and …

Mycobacterium abscessus is an emerging pathogen that is often refractory to antibiotic
control. Treatment is further complicated by considerable variation among clinical isolates in …

Mycobacterium abscessus is a member of the non-tuberculous mycobacteria (NTM) group,
responsible for chronic infections in individuals with cystic fibrosis (CF) or those otherwise …